← Leaderboards
Qingfei Jiang
University Of California, San Diego
$2,000,610
Attributed
$2,000,610
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $634.7K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,000,610 · 4
By mechanism
R01$952,971 · 1
K22$573,639 · 1
R03$474,000 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Eugene Wei-Ming Yeo$40,192,855
- Michael G Rosenfeld$73,496,650
- Christopher K Glass$71,096,171
- Maurice S Swanson$17,857,475
- Louise Chang Laurent$25,039,144
Others in their field
Other Emerging Leaders on “Therapy Resistant”
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- John Damon Chodera · Sloan-Kettering Inst Can Research$26,671,095
- Olwen Hahn · Brigham And Women'S Hospital$23,582,395
- Crystal Mackall · Children'S Hosp Of Philadelphia$16,367,876
- Ionut Bebu · George Washington University$14,057,850
Research focus
Therapy ResistantSelf-RenewalPreventMalignant NeoplasmsMutationNovel TherapeuticsMedicalCellsCell MaintenanceImpairmentAdenosineApoptosisMouse ModelGenesMediatingAcute T Cell LeukemiaCancer TypeLeukemia Initiating CellInosineCancer Stem CellDeaminaseFutureMalignant - DescriptorGene Expression
Grant awards (9)
Elucidate the Role of RNA Editing in Acute T-cell Lymphoblastic Leukemia Initiating Cells$476,737
R01 · FY2025 · CA · contact PI
Profiling Epitranscriptomic RNA editing in Pediatric Cancer$158,000
R03 · FY2025 · CA · contact PI
Elucidate the Role of RNA Editing in Acute T-cell Lymphoblastic Leukemia Initiating Cells$476,234
R01 · FY2024 · CA · contact PI
Profiling Epitranscriptomic RNA editing in Pediatric Cancer$158,000
R03 · FY2024 · CA · contact PI
Examine the function of APOBEC3B in epithelial ovarian cancer stem cells$79,000
R03 · FY2023 · CA · contact PI
Examine the function of APOBEC3B in epithelial ovarian cancer stem cells$79,000
R03 · FY2022 · CA · contact PI
Investigating the role of epitranscriptomic A-to-I RNA editing in T-cell acute lymphoblastic leukemia$191,213
K22 · FY2021 · CA · contact PI
Investigating the role of epitranscriptomic A-to-I RNA editing in T-cell acute lymphoblastic leukemia$191,213
K22 · FY2020 · CA · contact PI
Investigating the role of epitranscriptomic A-to-I RNA editing in T-cell acute lymphoblastic leukemia$191,213
K22 · FY2019 · CA · contact PI